Related Experiment Videos
Adjuvant interferon in the treatment of melanoma
British Journal of Cancer
|September 1, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.
British journal of cancer·2026
Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.
British journal of cancer·2026
Radiomics as a spatial context for treatment decision-making in head and neck cancer.
British journal of cancer·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Interleukin-10 in endometriosis: a systematic review of systemic and local immune compartment differences.
European journal of obstetrics, gynecology, and reproductive biology·2026
CBL0137 inhibits TFR2-mediated IgA1 deposition in IgA nephropathy.
International immunopharmacology·2026